• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGS

COGSTATE LTD

5.45% ! $2.32
Market Cap $376.5M  !
Technology Health Information Services
Add to My Watchlist

Cogstate Limited is a neuroscience technology company optimizing brain health assessments... Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CGS
Ann: Update - Notification of buy-back - CGS 		10/03/26 0 119
10/03/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  119 
CGS
Ann: Update - Notification of buy-back - CGS 		25/02/26 0 124
25/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
CGS
Ann: Update - Notification of buy-back - CGS 		24/02/26 0 143
TRENDING NEWS

Shell Walked Away at $400 Gold. The Gold Never Left.

Find out more right-arrow Created with Sketch.
NEWS
10 Mar 2026
24/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  143 
CGS
Ann: Cogstate 1H26 Financial Results 		23/02/26 5 1.0K
23/02/26 Last post  jellyroll Comments Created with Sketch.  5  Views Created with Sketch.  1.0K 
CGS
Ann: 1H25 Investor Presentation Materials 		19/02/26 0 190
19/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  190 
CGS
Ann: App 4D and Financial Statements Half-Year Ended 31 Dec 2025 		19/02/26 0 129
19/02/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  129 
CGS
Ann: Business Update & Preliminary 1H26 Results 		02/02/26 4 1.1K
02/02/26 Last post  jellyroll Comments Created with Sketch.  4  Views Created with Sketch.  1.1K 
CGS
Ann: Notification of cessation of securities - CGS 		15/01/26 0 149
15/01/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  149 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - CGS
10 Mar 08:50
 
Update - Notification of buy-back - CGS
25 Feb 08:10
 
Update - Notification of buy-back - CGS
24 Feb 08:16
 
1H25 Investor Presentation Materials
19 Feb 08:10
 
Cogstate 1H26 Financial Results
19 Feb 08:10
 
App 4D and Financial Statements Half-Year Ended 31 Dec 2025
19 Feb 08:10
 
View More arrow Created with Sketch.

Featured News

NEWS Syntara on advancing first-in-class Myelofibrosis therapy with multiple pipeline opportunities
right-arrow Created with Sketch.
NEWS Money and Investing: The superannuation wake up call for Australians
right-arrow Created with Sketch.
NEWS CEO Alex on Klevo's ASX comeback and global loyalty platform expansion
right-arrow Created with Sketch.
NEWS Dalaroo Metals: From West African gold belts to Greenland's critical minerals frontier
right-arrow Created with Sketch.
NEWS Expert Exchange: Where to for Zip Co in 2026? The Trader vs the Journalist
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast #044 – Operation Epic Fury
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.32 		Change
0.120(5.45%) 		Mkt cap ! $376.5M
Open High Low Volume
$2.21 $2.34 $2.21 185.7K

Buyers (Bids)

Vol. Price($)
1300 $2.32
 

Sellers (Offers)

Price($) Vol.
$2.33 389
Last trade - 16.18pm 10/03/2026 (20 minute delay) ?
CGS (ASX) Chart

Top Stories

Expert Exchange: Where to for Zip Co in 2026? The Trader vs the Journalist

Here on HotCopper, we’re digging into our Expert Exchange series for CY26, tapping the greatest minds in the Australian finance and investment landscape for their two cents on what HotCopper users are dying to know.Listen to the HotCopper podcast for in-depth discussions and insig...
As BHP battles China over iron prices – now Mongolia wants a word with Rio Tinto about copper Rio Tinto has found itself in a negotiation with the Mongolian gov't, not too unlike the situation in which BHP has found itself in recently.
Listen: HotCopper Wire Podcast #044 – Operation Epic Fury In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson dive into the conflict in the Middle East, talking about the U.S-Israeli attacks on Iran, how the global situation is and will impact Australian shares, and what it might mean for our ongoing struggle with...
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Paradigm Biopharma (ASX:PAR) founder and managing director Paul Rennie about Paradigm arriving at its @pivotal” phase three trial, which will be examining outcomes of its flagshi...
Syntara on advancing first-in-class Myelofibrosis therapy with multiple pipeline opportunities Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Syntara Ltd (ASX:SNT) chief Gary Phillips for a high-level overview on the biotech company’s objectives in treating blood cancers and fibrosis, what underpins its value proposition, an...

Featured News

NEWS HotList stocks: OD6 Metals, Woodside Energy, Viking Mines, and other trending companies in Week 10
right-arrow Created with Sketch.
NEWS Dalaroo Metals: From West African gold belts to Greenland's critical minerals frontier
right-arrow Created with Sketch.
NEWS 9th March: The ASX200 is down -3% and Brent Crude is over US$100/bbl
right-arrow Created with Sketch.
NEWS Expert Exchange: Where to for Zip Co in 2026? The Trader vs the Journalist
right-arrow Created with Sketch.
NEWS Syntara on advancing first-in-class Myelofibrosis therapy with multiple pipeline opportunities
right-arrow Created with Sketch.
NEWS Boss Energy's Honeymoon uranium production impacted by rain
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.